Adaptimmune Therapeutics - 48 Year Dividend History | ADAP

Historical dividend payout and yield for Adaptimmune Therapeutics (ADAP) since 1971. The current TTM dividend payout for Adaptimmune Therapeutics (ADAP) as of April 18, 2019 is $0.00. The current dividend yield for Adaptimmune Therapeutics as of April 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.431B $0.060B
Adaptimmune Therapeutics plc is a biopharmaceutical company. The Company is focused on cancer immunotherapy products based on T-cell receptor platform. Adaptimmune Therapeutics plc is based in Abingdon, United Kingdom.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.313B 12.32
Gilead Sciences (GILD) United States $80.293B 10.22
Bio-Techne Corp (TECH) United States $7.144B 48.13